Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest update is out from Halma plc ( (GB:HLMA) ).
Halma plc has appointed Hudson La Force as an independent non-executive Director, effective 2 June 2025. Hudson’s extensive industrial and international experience, including his previous role as CEO of W. R. Grace & Co., is expected to enhance the board’s capabilities, particularly with his insights from the US and China markets.
The most recent analyst rating on (GB:HLMA) stock is a Buy with a £31.00 price target. To see the full list of analyst forecasts on Halma plc stock, see the GB:HLMA Stock Forecast page.
Spark’s Take on GB:HLMA Stock
According to Spark, TipRanks’ AI Analyst, GB:HLMA is a Outperform.
Halma plc’s overall stock score reflects its strong financial performance and positive earnings call insights, highlighting record revenue and growth prospects. The technical analysis provides mixed signals, with some resistance noted in price trends. Valuation metrics indicate the stock may be overvalued, potentially limiting upside. Despite risks in the Healthcare sector and currency headwinds, the company’s robust cash generation and strategic acquisitions support its growth trajectory.
To see Spark’s full report on GB:HLMA stock, click here.
More about Halma plc
Halma plc is a FTSE 100 global group specializing in life-saving technology. The company focuses on providing innovative solutions across various industries, enhancing safety, health, and environmental protection.
Average Trading Volume: 754,617
Technical Sentiment Signal: Buy
Current Market Cap: £11.24B
Learn more about HLMA stock on TipRanks’ Stock Analysis page.